NADA Number: 140-901

Proprietary Name Adequan®
Sponsor Luitpold Pharmaceuticals, Inc.
Ingredients Polysulfated Glycosaminoglycan
Species Horse, not for meat production
Routes of Administration Intra-articular
Intramuscular
Dose Form Liquid
Drug Form Liquid
Dispensing Status RX
Dosage Amount,
Indications
& Limitations

522.1850 Polysulfated glycosaminoglycan.

Specifications: Each 5-milliliter ampule or vial contains 500 milligrams.

Conditions of use:

Horses

Amount: 250 milligrams intra-articularly (carpal) once a week for 5 weeks or 500 milligrams intramuscularly (carpal and hock) every 4 days for 28 days. Injection site must be thoroughly cleansed prior to injection.

Indications: Polysulfated glycosaminoglycan is for the treatment of noninfectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

Limitations: Do not use in horses intended for human consumption. Safe use in breeding animals has not been established. Federal law restricts this drug to use by or on the order of a licensed veterinarian.